{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:15:10Z","timestamp":1772021710487,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.3816\/clc.2003.n.004","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:08:26Z","timestamp":1221080906000},"page":"237-241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine\/Cisplatin\u2013Treated Advanced Non\u2013Small-Cell Lung Cancer Patients"],"prefix":"10.3816","volume":"4","author":[{"given":"Carlos","family":"Camps","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Sarries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara","family":"Roig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Javier S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Queralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natividad","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Tar\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Rosell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLC.2003.n.004_bib1","series-title":"The Cancer Handbook","first-page":"293","article-title":"The formation of DNA adducts","author":"Phillips","year":"2002"},{"key":"10.3816\/CLC.2003.n.004_bib2","series-title":"The Cancer Handbook","first-page":"1295","article-title":"Mechanisms of action of cancer chemotherapeutic agents: DNAinteractive alkylating agents and antitumour platinum-based drugs","author":"Siddik","year":"2002"},{"key":"10.3816\/CLC.2003.n.004_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0921-8777(00)00071-9","article-title":"Controlling the efficiency of excision repair","volume":"485","author":"Hanawalt","year":"2001","journal-title":"Mutat Res"},{"key":"10.3816\/CLC.2003.n.004_bib4","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/S0021-9258(18)53902-8","article-title":"Repair of individual DNA strands in the hamster dihydrofolate reductase gene after treatment with ultraviolet light, alkylating agents, and cisplatin","volume":"268","author":"May","year":"1993","journal-title":"J Biol Chem"},{"key":"10.3816\/CLC.2003.n.004_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.onc.1201963","article-title":"Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis","volume":"17","author":"McKay","year":"1998","journal-title":"Oncogene"},{"key":"10.3816\/CLC.2003.n.004_bib6","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.1021\/bi982685+","article-title":"Inhibition of RNA polymerase II transcription in human cell extracts by cisplatin DNA damage","volume":"38","author":"Cullinane","year":"1999","journal-title":"Biochemistry"},{"key":"10.3816\/CLC.2003.n.004_bib7","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1038\/sj.onc.1203583","article-title":"Proneness to UV-induced apoptosis in human fibroblasts defective in transcription coupled repair is associated with the lack of Mdm2 transactivation","volume":"19","author":"Conforti","year":"2000","journal-title":"Oncogene"},{"key":"10.3816\/CLC.2003.n.004_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3835(01)00690-5","article-title":"Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors","volume":"174","author":"Takebayashi","year":"2001","journal-title":"Cancer Lett"},{"key":"10.3816\/CLC.2003.n.004_bib9","series-title":"The Cancer Handbook","first-page":"1507","article-title":"DNA repair and the cell cycle as targets in cancer therapy","author":"Rajewsky","year":"2002"},{"key":"10.3816\/CLC.2003.n.004_bib10","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1038\/sj.onc.1204901","article-title":"p53 plays a protective role against UV- and cisplatin-induced apoptosis in transcription-coupled repair proficient fibroblasts","volume":"20","author":"McKay","year":"2001","journal-title":"Oncogene"},{"key":"10.3816\/CLC.2003.n.004_bib11","first-page":"4899","article-title":"Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells","volume":"62","author":"Furuta","year":"2002","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2003.n.004_bib12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1200\/JCO.1998.16.1.309","article-title":"ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy","volume":"16","author":"Metzger","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLC.2003.n.004_bib13","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI117388","article-title":"Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy","volume":"94","author":"Dabhulkar","year":"1994","journal-title":"J Clin Invest"},{"key":"10.3816\/CLC.2003.n.004_bib14","first-page":"2286","article-title":"Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small-cell lung cancer","volume":"8","author":"Lord","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLC.2003.n.004_bib15","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients","volume":"61","author":"Spitz","year":"2001","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2003.n.004_bib16","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/jnci\/94.14.1091","article-title":"An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer","volume":"94","author":"Bosken","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLC.2003.n.004_bib17","first-page":"4760","article-title":"Elevated DNA capacity is associated with intrinsic resistance of lung cancer to chemotherapy","volume":"55","author":"Zeng-Rong","year":"1995","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2003.n.004_bib18","first-page":"4103","article-title":"Reduced DNA repair capacity in lung cancer patients","volume":"56","author":"Wei","year":"1996","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2003.n.004_bib19","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/jnci\/92.21.1764","article-title":"Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study","volume":"92","author":"Wei","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLC.2003.n.004_bib20","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/carcin\/21.8.1527","article-title":"Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis","volume":"21","author":"Cheng","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.3816\/CLC.2003.n.004_bib21","first-page":"801","article-title":"Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcriptionpolymerase chain reaction","volume":"8","author":"Cheng","year":"1999","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.3816\/CLC.2003.n.004_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0921-8777(00)00051-3","article-title":"DNA repair capacity: inconsistency between effect of over-expression of five NER genes and the correlation to mRNA levels in primary lymphocytes","volume":"461","author":"Vogel","year":"2000","journal-title":"Mutat Res"},{"key":"10.3816\/CLC.2003.n.004_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/cncr.10231","article-title":"Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck","volume":"94","author":"Cheng","year":"2002","journal-title":"Cancer"},{"key":"10.3816\/CLC.2003.n.004_bib24","first-page":"8654","article-title":"A xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer","volume":"61","author":"Park","year":"2001","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2003.n.004_bib25","first-page":"5457","article-title":"Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD","volume":"62","author":"Aloyz","year":"2002","journal-title":"Cancer Res"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411702868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411702868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:57:45Z","timestamp":1761505065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730411702868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S1525730411702868"],"URL":"https:\/\/doi.org\/10.3816\/clc.2003.n.004","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of Nucleotide Excision Repair XPD Polymorphisms in the Peripheral Blood of Gemcitabine\/Cisplatin\u2013Treated Advanced Non\u2013Small-Cell Lung Cancer Patients","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLC.2003.n.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}